서린바이오

038070KOSDAQ기타 전문 도매업

50.3 / 100

Reference Date: 2026-07-24

Financial Score14.0 / 40

News Sentiment21.3 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 1.4% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Sorin Bio operates as a 'Global Total Solutions Provider in Life Science & Healthcare', focusing on bio industry solutions, sanitation/sterilization services, AI-based bio analysis, and healthcare. Approximately 97.2% of its revenue comes from bio industry total solutions, which includes supplying raw materials, reagents, and equipment essential for biopharmaceutical development to research institutions and pharmaceutical companies.

Number of Employees

110people

Average Salary

60.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

71.33Industry Average 12.750.0Point

5.6x industry avg (risky)

PBR

0.48Industry Average 0.584.0Point

In line with industry avg

ROE

0.66Industry Average 2.091.0Point

Well below industry avg

Debt Ratio

1.25Industry Average 7.878.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼6.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼44.6% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 0.5% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
서린바이오 "POCUS, 레비티 공식 서비스 인증"
서린바이오의 POCUS 플랫폼이 레비티로부터 공식 서비스 인증을 받아 기술 경쟁력과 신뢰성이 강화되었다.
Positive
서린바이오, 레비티와 협력…초고감도 면역시험분석 서비스 론칭
서린바이오가 레비티와의 협력으로 초고감도 면역시험 분석 서비스를 론칭하며 고부가가치 연구지원 서비스 확장을 통해 긍정적인 시장 반응을 얻고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 4,400Won52-week high 7,55952-week low 4,100

1-month return3.0Point

1m -1.35% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0